Latest news
Loading news…
Vega Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. South San Francisco, California, United States Founded 2018 11-50 employees For Profit
Vega Therapeutics is a biotechnology company that develops antibody-based therapies for rare bleeding and blood disorders.
Vega Therapeutics was acquired by Incyte in 2026 for $1B.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
1
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 2
- IT spend
- $59K
Company Info
- Founded
- 2018
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 40
- HQ
- South San Francisco, California, United States
- Region
- San Francisco Bay Area, West Coast, Western US
- Exit date
- Jun 8, 2026
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- -0.4
- Trend (30d)
- -0.8
- Trend (90d)
- 9.3
1
professional contacts at Vega Therapeutics
Contact execs at Vega Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Vega Therapeutics
Loading news…
FAQs about Vega Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.